Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Anticancer Research|June 6, 1998
The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosisP Nandy, A P Periclou, V I AvramisAnticancer Research|November 29, 2001
Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell linesI A Avramis, R Kwock, V I AvramisIn Vivo (Athens, Greece)|July 25, 2000
Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT)A P Periclou, P Nandy, V I AvramisActa Oncologica (Stockholm, Sweden)|January 1, 1994
Antileukemic activity studies and cellular pharmacology of the analogues of 2-hydroxy-1H-isoindole-1,3-dione (HISD) alone and in combination with cytosine arabinoside (ara-C) against human leukemia cells CEM/0P Nandy, E J Lien, V I AvramisPharmaceutical Research|April 1, 1993
Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C)P B Koneru, E J Lien, V I AvramisCancer Chemotherapy and Pharmacology|January 1, 1989
Cellular metabolism of 5,6-dihydro-5-azacytidine and its incorporation into DNA and RNA of human lymphoid cells CEM/O and CEM/dCk(-)V I Avramis, W C Powell, R A MecumCancer Chemotherapy and Pharmacology|January 1, 1989
Cellular metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA and RNA of human lymphoid CEM/0 and CEM/dCk(-) cellsV I Avramis, W C Powell, R A MecumCurrent Medicinal Chemistry|April 29, 2010
Structure-function relationships and clinical applications of L-asparaginasesN E Labrou, A C Papageorgiou, V I AvramisAIDS (London, England)|July 1, 1989
Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM)V I Avramis, W Markson, R L Jackson, et al.Journal of Acquired Immune Deficiency Syndromes|December 1, 1993
Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infectionV I Avramis, R Kwock, M M Solorzano, et al.Pageof 5